Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus
- PMID: 8285612
- PMCID: PMC192385
- DOI: 10.1128/AAC.37.11.2318
Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus
Abstract
The uptake of azithromycin by human monocytes and the intracellular antibacterial activity of azithromycin against Staphylococcus aureus were investigated. With an extracellular pH of 6.9, the maximum intracellular concentration of azithromycin in monocytes was about six times the extracellular concentration. The half-life for diffusion was 44 min. The results support the view that no active transport is involved in the intracellular accumulation of azithromycin. In cell-free medium, the maximum effect of azithromycin on S. aureus was bacteriostasis, which was achieved at a concentration of 5 mg/liter. In contrast, concentrations greater than 1.5 mg of azithromycin per liter were bactericidal for S. aureus ingested by monocytes. The difference in maximum growth inhibition on S. aureus for the two conditions was 0.1.68 h-1 (95% confidence interval, 0.128 to 0.208). The concentration of the drug that achieved 50% of the maximum effect was 0.434 mg/liter for both conditions. The enhancement of the effect on S. aureus ingested by monocytes suggests that the intracellular environment in human monocytes favors the antibacterial action of azithromycin. Enhancement of the antibacterial activity of azithromycin was not observed with granulocytes.
Similar articles
-
The influence of human granulocytes and monocytes on the antibacterial activity of cefetamet against Staphylococcus aureus.J Antimicrob Chemother. 1995 May;35(5):611-22. doi: 10.1093/jac/35.5.611. J Antimicrob Chemother. 1995. PMID: 7592174
-
Intracellular activity of trovafloxacin against Staphylococcus aureus.J Antimicrob Chemother. 1999 Aug;44(2):193-9. doi: 10.1093/jac/44.2.193. J Antimicrob Chemother. 1999. PMID: 10473225
-
Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions.Antimicrob Agents Chemother. 1996 Jan;40(1):75-9. doi: 10.1128/AAC.40.1.75. Antimicrob Agents Chemother. 1996. PMID: 8787883 Free PMC article. Clinical Trial.
-
Phagocyte uptake and transport of azithromycin.Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):828-33. doi: 10.1007/BF01975835. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1662626 Review.
-
[Pharmacological and pharmacokinetic properties of azithromycin (Zithromac), a novel 15-membered ring macrolide antibacterial agent].Nihon Yakurigaku Zasshi. 2001 May;117(5):343-9. doi: 10.1254/fpj.117.343. Nihon Yakurigaku Zasshi. 2001. PMID: 11411344 Review. Japanese.
Cited by
-
The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.Infect Immun. 1997 Jul;65(7):2792-802. doi: 10.1128/iai.65.7.2792-2802.1997. Infect Immun. 1997. PMID: 9199452 Free PMC article.
-
Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.Clin Microbiol Rev. 2002 Oct;15(4):647-79. doi: 10.1128/CMR.15.4.647-679.2002. Clin Microbiol Rev. 2002. PMID: 12364374 Free PMC article. Review.
-
Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish.Sci Total Environ. 2021 Oct 10;790:148129. doi: 10.1016/j.scitotenv.2021.148129. Epub 2021 May 29. Sci Total Environ. 2021. Retraction in: Sci Total Environ. 2024 Dec 20;957:177814. doi: 10.1016/j.scitotenv.2024.177814. PMID: 34380260 Free PMC article. Retracted.
-
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group.Antimicrob Agents Chemother. 2000 Jul;44(7):1796-802. doi: 10.1128/AAC.44.7.1796-1802.2000. Antimicrob Agents Chemother. 2000. PMID: 10858333 Free PMC article. Clinical Trial.
-
Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines.Inflamm Res. 2013 Mar;62(3):259-73. doi: 10.1007/s00011-012-0574-z. Epub 2012 Nov 15. Inflamm Res. 2013. PMID: 23229721
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources